Skip to content
Esta página está disponible en españolCambiar →
GestorLensSign up

Cellebrite DI (CLBT): which funds own it

Information Technology →Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 5, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Follow CLBT for free
Share

Sections with a free account

8 concentrated managers hold it; combined they have held more shares for 4 quarters in a row (5 added, 1 trimmed). Its median weight in those portfolios is 2.2%.

Who owns Cellebrite DI?

Holders reporting more than 5% of the shares to the SEC (Schedules 13D/13G): Suncorporation, 42.7% (13G/A filed Feb 24, 2026), Adam H. Clammer, 6.1% (13D/A filed Mar 20, 2025), Pertento Partners LLP, 5.2% (13G filed Oct 9, 2026) and Voss Capital, 5.1% (13G filed Aug 18, 2026). As of Jun 30, 2026, the largest holders reported on Form 13F were True Wind Capital Management (5.6% of the shares), Voss Capital (4.6%) and Pertento Partners LLP (3.2%).

Which institutions hold the most Cellebrite DI shares?

Per Form 13F filings as of Jun 30, 2026, as a share of all shares outstanding:

  1. 1. True Wind Capital Management: 5.6%
  2. 2. Voss Capital: 4.6%
  3. 3. Pertento Partners LLP: 3.2%
  4. 4. Phoenix Financial: 2.5%
  5. 5. FMR: 2.4%
  6. 6. BlackRock: 2.3%
  7. 7. Nine Ten Capital Management: 1.7%
  8. 8. Artisan Partners Limited Partnership: 1.3%
  9. 9. Wellington Management Group LLP: 1.2%
  10. 10. Clal Insurance Enterprises Holdings: 1.1%

How much of Cellebrite DI do institutions own?

The 202 institutions that file 13F reported 50.3% of the shares as of Jun 30, 2026.

Sources:13G/A by Suncorporation (Feb 24, 2026) ↗13D/A by Adam H. Clammer (Mar 20, 2025) ↗13G by Pertento Partners LLP (Oct 9, 2026) ↗13G by Voss Capital (Aug 18, 2026) ↗All of the company's proxy statements on EDGAR ↗

13F percentages divide the shares each institution reports by the shares outstanding on the cover of the company's latest report before the quarter end (Feb 23, 2026). Entities of the same group file separately and are not added up. We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

Cellebrite DI revenue

Cellebrite DI reported annual revenue of $475.7 million for fiscal year 2025 (year ended December 31, 2025), according to its Form 20-F filed with the SEC (XBRL data).

Concentrated managers
8
All 13F: 202
Consensus
72/100
across 8 concentrated managersRanks by accumulation, portfolio weight and number of managers; it does not say more are buying than selling.
Price at Jun 30, 2026 (per 13F)
$14.6
+6.0% in the quarter · reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Change in managers (8 → 8): 1 opened · 1 exited = 0

Net flow in the quarter: +$48.1M (+3.3 M shares) · bought $78.6M and sold $30.5MShares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.

Accumulation: combined they have held more shares for 4 quarters in a row (5 added, 1 trimmed). It is the combined share count of those still holding it: one large buyer can outweigh many who trimmed.

The set of concentrated managers changed between quarters: with the set as it was then, 10 held it last quarter (the chart point); with today's set, 8 (the base for the change).

Concentrated managers holding it

Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.

Other relevant holders

Filers with $100M or more in the stock that do not count as concentrated managers because of their type: they are left out of the counts, the consensus and the accumulation.

  • True Wind Capital ManagementSingle-position portfolio$156M100.0%

Largest holders of CLBT (all 13F filers)

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Held by institutions (13F)

Institutions (13F): 50.3% of the shares · top 10: 25.8% · in index firms: 6.3% of the institutional total

Share of the stock held by 13F filers

Q2 2026: 50.3%

50.8%20.4%
Q1 2022Q2 2026

Shares reported by the 202 13F filers as of Jun 30, 2026, divided by the shares outstanding on the cover of the company's latest report (Feb 23, 2026). It is not all institutional ownership: only managers above $100M file a 13F, and it excludes short positions. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. We only publish it where the figure is credible: not for ADRs, companies with more than one share class or stale shares-outstanding data.

Fundamentals

12-month figures to Dec 31, 2025 · balance sheet as of Dec 31, 2025.

Profitability
Operating margin
14.0%
Net margin
16.5%
ROE
16.2%
Growth
Revenue (TTM)
$476M
Revenue growth
18.6%
Net income (TTM)
$78.3M
Balance sheet
Net debt / EBITDA
—
Free cash flow (TTM)
$160M
Quality vs sector
64/100

Figures from the statements the company filed with the SEC (10-K, 10-Q). Free cash flow = operating cash flow − capital expenditures; empty if the company does not report capex. “Quality vs sector”: 0 to 100, the average of its percentiles in ROE, operating margin, free-cash-flow margin, revenue and earnings growth and net debt / EBITDA (at least 3 needed) against companies in its sector above $300M. How each figure is calculated

Shares outstanding: buybacks and dilution

Diluted shares by fiscal year (split-adjusted)

2025: 249.9 M

249.9 M0
20212025
1 year
+19.3%
3 years
+27.9%
5 years
no data
Buybacks (FY 2025)
no data
Share issuance
no data
Stock-based compensation
$44.9M9.4% of revenue
Dividends paid
no data

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

Operating cash flow ÷ net income (12 months)
2.22
Interest coverage (operating income ÷ interest)
no data
Debt due within 12 months
no data

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Insiders (Form 4)

Officers and directors who bought (6 m)
0
Amount (6 m)
$0
CEO/CFO bought (12 m)
No

10% owners who bought (6 m): 0

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗

Other Information Technology stocks in managers' portfolios

Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.

All of Information Technology →

Follow CLBT for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow CLBT